Stay updated on Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page.

Latest updates to the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previous study record content with a generic error page. This blocks access to the study details and links on that URL.SummaryDifference19%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe revision tag on the page was updated to v3.6.6. This represents a minor version update to the page’s backend/template version with no visible changes to study content.SummaryDifference0.1%

- Check45 days agoChange Detected- The page revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page. No study details or user-facing content appear to have changed.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a minor update to the page template or metadata. This does not alter the study content or visible information beyond the version label.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page's revision tag updated from v3.6.2 to v3.6.3, indicating a newer version.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page's revision label has been updated from v3.6.0 to v3.6.2, indicating a small internal update to the page template or CMS.SummaryDifference0.1%

Stay in the know with updates to Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page.